| Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs A Bindoli, MP Rigobello, G Scutari, C Gabbiani, A Casini, L Messori Coordination Chemistry Reviews 253 (11-12), 1692-1707, 2009 | 674 | 2009 |
| Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies S Nobili, E Mini, I Landini, C Gabbiani, A Casini, L Messori Medicinal research reviews 30 (3), 550-580, 2010 | 603 | 2010 |
| Gold (III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold (III) compounds L Messori, F Abbate, G Marcon, P Orioli, M Fontani, E Mini, T Mazzei, ... Journal of medicinal chemistry 43 (19), 3541-3548, 2000 | 456 | 2000 |
| NAMI-A and KP1019/1339, two iconic ruthenium anticancer drug candidates face-to-face: A case story in medicinal inorganic chemistry E Alessio, L Messori Molecules 24 (10), 1995, 2019 | 392 | 2019 |
| Gold (III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties G Marcon, S Carotti, M Coronnello, L Messori, E Mini, P Orioli, T Mazzei, ... Journal of Medicinal Chemistry 45 (8), 1672-1677, 2002 | 355 | 2002 |
| Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium (II)− arene compounds A Casini, C Gabbiani, F Sorrentino, MP Rigobello, A Bindoli, TJ Geldbach, ... Journal of medicinal chemistry 51 (21), 6773-6781, 2008 | 345 | 2008 |
| Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc (II) and copper (II) complexes M Di Vaira, C Bazzicalupi, P Orioli, L Messori, B Bruni, P Zatta Inorganic chemistry 43 (13), 3795-3797, 2004 | 337 | 2004 |
| Gold (III) compounds as anticancer agents: Relevance of gold–protein interactions for their mechanism of action A Casini, C Hartinger, C Gabbiani, E Mini, PJ Dyson, BK Keppler, ... Journal of inorganic biochemistry 102 (3), 564-575, 2008 | 333 | 2008 |
| The binding properties of two antitumor ruthenium (III) complexes to apotransferrin. F Kratz, M Hartmann, B Keppler, L Messori Journal of Biological Chemistry 269 (4), 2581-2588, 1994 | 311 | 1994 |
| Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives M Navarro, C Gabbiani, L Messori, D Gambino Drug discovery today 15 (23-24), 1070-1078, 2010 | 274 | 2010 |
| Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions MP Rigobello, L Messori, G Marcon, MA Cinellu, M Bragadin, A Folda, ... Journal of inorganic biochemistry 98 (10), 1634-1641, 2004 | 252 | 2004 |
| Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold (III) compounds with bipyridyl ligands A Casini, MA Cinellu, G Minghetti, C Gabbiani, M Coronnello, E Mini, ... Journal of Medicinal Chemistry 49 (18), 5524-5531, 2006 | 246 | 2006 |
| Molecular mechanisms and proposed targets for selected anticancer gold compounds A Casini, L Messori Current topics in medicinal chemistry 11 (21), 2647-2660, 2011 | 216 | 2011 |
| Aluminum, copper, iron and zinc differentially alter amyloid-Aβ1–42 aggregation and toxicity S Bolognin, L Messori, D Drago, C Gabbiani, L Cendron, P Zatta The international journal of biochemistry & cell biology 43 (6), 877-885, 2011 | 207 | 2011 |
| A spectroscopic study of the reaction of NAMI, a novel ruthenium (III) anti‐neoplastic complex, with bovine serum albumin L Messori, P Orioli, D Vullo, E Alessio, E Iengo European journal of biochemistry 267 (4), 1206-1213, 2000 | 201 | 2000 |
| New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications AR Sannella, A Casini, C Gabbiani, L Messori, AR Bilia, FF Vincieri, ... FEBS letters 582 (6), 844-847, 2008 | 199 | 2008 |
| Gold (III) compounds as anticancer drugs C Gabbiani, A Casini, L Messori Gold Bulletin 40, 73-81, 2007 | 191 | 2007 |
| Challenges associated with metal chelation therapy in Alzheimer's disease ML Hegde, P Bharathi, A Suram, C Venugopal, R Jagannathan, P Poddar, ... Journal of Alzheimer's Disease 17 (3), 457-468, 2009 | 190 | 2009 |
| A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin … A Ilari, P Baiocco, L Messori, A Fiorillo, A Boffi, M Gramiccia, T Di Muccio, ... Amino acids 42, 803-811, 2012 | 189 | 2012 |
| A comparative study of aluminum (III), gallium (III), indium (III), and thallium (III) binding to human serum transferrin WR Harris, L Messori Coordination Chemistry Reviews 228 (2), 237-262, 2002 | 182 | 2002 |
Chiara GabbianiDepartment of Chemistry and Industrial ChemistryBestätigte E-Mail-Adresse bei dcci.unipi.it
